Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis

Original Article

O.V.D. Meeren, M. Hatherill, V. Nduba, R.J. Wilkinson, M. Muyoyeta, E.V. Brakel, H.M. Ayles, G. Henostroza, F. Thienemann, T.J. Scriba, A. Diacon, G.L. Blatner, M.-A. Demoitié, M. Tameris, M. Malahleha, J.C. Innes, E. Hellström, N. Martinson, T. Singh, E.J. Akite, A.K. Azam, A. Bollaerts, A.M. Ginsberg, T.G. Evans, P. Gillard, and D.R. Tait

N Engl J Med 2018;379:1621-1634

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
10/24/2018
Course expires: 
10/25/2020

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Sunday, October 25, 2020 - 11:59pm.